American Diabetes Association

Skip to Main Content

Table 2 —

Outcome measures of all 314 (84%) of type 2 diabetic patients with postintervention data

	n	Baseline	Mean change	P
HbA_1c (%)
Experimental	137	7.7 ± 0.2	−0.3 ± 0.1	0.02
Control	133	7.9 ± 0.2	−0.2 ± 0.1	0.18
Systolic blood pressure (mmHg)
Experimental	158	143 ± 1.8	−6.3 ± 2.1	0.003
Control	155	141 ± 1.8	−1.0 ± 1.9	0.61
Diastolic blood pressure (mmHg)
Experimental	158	77 ± 0.90	−2.4 ± 1.1	0.03
Control	154	77 ± 0.96	−1.6 ± 1.2	0.19
Cholesterol (mmol/l)
Experimental	158	5.46 ± 0.10	−0.25 ± 0.08	0.0006
Control	157	5.39 ± 0.10	−0.06 ± 0.09	0.45

	n	Baseline	Mean change	P
HbA_1c (%)
Experimental	137	7.7 ± 0.2	−0.3 ± 0.1	0.02
Control	133	7.9 ± 0.2	−0.2 ± 0.1	0.18
Systolic blood pressure (mmHg)
Experimental	158	143 ± 1.8	−6.3 ± 2.1	0.003
Control	155	141 ± 1.8	−1.0 ± 1.9	0.61
Diastolic blood pressure (mmHg)
Experimental	158	77 ± 0.90	−2.4 ± 1.1	0.03
Control	154	77 ± 0.96	−1.6 ± 1.2	0.19
Cholesterol (mmol/l)
Experimental	158	5.46 ± 0.10	−0.25 ± 0.08	0.0006
Control	157	5.39 ± 0.10	−0.06 ± 0.09	0.45

Data are means ± SEM.